NOS2 and SPSB1

Number of citations of the paper that reports this interaction (PMID 20603330)
17

Data Source:
BioGRID (pull down, affinity chromatography technology)

		NOS2	SPSB1
Gene Name		nitric oxide synthase 2, inducible	splA/ryanodine receptor domain and SOCS box containing 1
Image
Gene Ontology Annotations	Cellular Component	Intracellular Nucleus Cytoplasm Peroxisome Cytosol Cortical Cytoskeleton Perinuclear Region Of Cytoplasm	Cytoplasm
	Molecular Function	NADPH-hemoprotein Reductase Activity Nitric-oxide Synthase Activity Receptor Binding Iron Ion Binding Protein Binding Calmodulin Binding FMN Binding Heme Binding Tetrahydrobiopterin Binding Arginine Binding Protein Homodimerization Activity Flavin Adenine Dinucleotide Binding NADP Binding	Protein Binding
	Biological Process	Response To Hypoxia Positive Regulation Of Leukocyte Mediated Cytotoxicity Innate Immune Response In Mucosa Arginine Catabolic Process Superoxide Metabolic Process Nitric Oxide Biosynthetic Process Inflammatory Response Nitric Oxide Mediated Signal Transduction Blood Coagulation Circadian Rhythm Response To Bacterium Negative Regulation Of Gene Expression Peptidyl-cysteine S-nitrosylation Positive Regulation Of Guanylate Cyclase Activity Regulation Of Cell Proliferation Negative Regulation Of Protein Catabolic Process Defense Response To Bacterium Regulation Of Cellular Respiration Negative Regulation Of Blood Pressure Positive Regulation Of Vasodilation Regulation Of Insulin Secretion Defense Response To Gram-negative Bacterium Interaction With Host Positive Regulation Of Killing Of Cells Of Other Organism Oxidation-reduction Process Cellular Response To Lipopolysaccharide Cellular Response To Interferon-gamma Phagosome Maturation	Protein Ubiquitination Intracellular Signal Transduction
Pathways		Platelet homeostasis Phagosomal maturation (early endosomal stage) Latent infection of Homo sapiens with Mycobacterium tuberculosis Nitric oxide stimulates guanylate cyclase	Antigen processing: Ubiquitination & Proteasome degradation Class I MHC mediated antigen processing & presentation Adaptive Immune System
Drugs		L-Arginine L-Citrulline Miconazole Dexamethasone N,N-dimethylarginine 4r-Fluoro-N6-Ethanimidoyl-L-Lysine 3-Bromo-7-Nitroindazole N-(3-(Aminomethyl)Benzyl)Acetamidine 7-Nitroindazole Ethylisothiourea Thiocoumarin Aminoguanidine S-Ethylisothiourea N-Omega-Propyl-L-Arginine (6r,1\'r,2\'s)-5,6,7,8 Tetrahydrobiopterin Heme 6-Nitroindazole N-Omega-Hydroxy-L-Arginine 7,8-Dihydro-L-Biopterin N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine L-Thiocitrulline 7,8-Dihydrobiopterin 5-Nitroindazole 5-(4\'-AMINO-1\'-ETHYL-5\',8\'-DIFLUORO-1\'H-SPIRO[PIPERIDINE-4,2\'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE 4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile (2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine (3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE (3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE 1-(6-CYANO-3-PYRIDYLCARBONYL)-5\',8\'-DIFLUOROSPIRO[PIPERIDINE-4,2\'(1\'H)-QUINAZOLINE]-4\'-AMINE 4-(1H-IMIDAZOL-1-YL)PHENOL 1-[4-(AMINOMETHYL)BENZOYL]-5\'-FLUORO-1\'H-SPIRO[PIPERIDINE-4,2\'-QUINAZOLIN]-4\'-AMINE Triflusal
Diseases
GWAS		Crohn's disease ( 23128233) Psoriasis ( 20953189)	Dental caries ( 23064961) Immune response to anthrax vaccine ( 22658931) Response to tocilizumab in rheumatoid arthritis ( 22491018)
Protein-Protein Interactions		11 interactors: ACTB ACTN4 CAV1 PEX5 RAC1 RAC2 SLC9A3R1 SPSB1 SPSB2 SPSB4 SRC	10 interactors: ATM DDX4 KDM1A MET NOS2 PAWR PRMT1 PRMT6 RASA1 SUV39H1
Entrez ID		4843	80176
HPRD ID		01225	18106
Ensembl ID		ENSG00000007171	ENSG00000171621
Uniprot IDs		P35228	Q96BD6
PDB IDs		1NSI 2LL6 2NSI 3E7G 3EJ8 3HR4 4NOS	2JK9 3F2O
Enriched GO Terms of Interacting Partners?		Blood Coagulation Hemostasis Platelet Activation Regulation Of Body Fluid Levels Vascular Endothelial Growth Factor Receptor Signaling Pathway Wound Healing Tissue Remodeling Cellular Component Assembly Regulation Of Cellular Component Movement Response To Wounding Bone Resorption Tissue Homeostasis Regulation Of Endocytosis Cell-cell Junction Organization Bone Remodeling Regulation Of Sodium:proton Antiporter Activity Negative Regulation Of Protein Homooligomerization Signal Transduction Multicellular Organismal Homeostasis Actin Cytoskeleton Organization Intracellular Signal Transduction Signaling T Cell Costimulation Actin Filament-based Process Cell Communication Negative Regulation Of Protein Oligomerization Cell Activation Locomotion Actin Filament Organization Regulation Of Hydrogen Peroxide Metabolic Process Organelle Organization Ephrin Receptor Signaling Pathway Regulation Of Respiratory Burst Homeostatic Process Positive Regulation Of Cellular Component Movement Regulation Of Proton Transport Positive Regulation Of Lamellipodium Assembly Negative Regulation Of Anoikis Regulation Of Vesicle-mediated Transport Regulation Of Cell Projection Assembly Movement Of Cell Or Subcellular Component Axon Guidance Membrane Organization Regulation Of Platelet-derived Growth Factor Receptor Signaling Pathway Cellular Response To Stimulus Positive Regulation Of Lamellipodium Organization Regulation Of Anoikis Positive Regulation Of Immune System Process Regulation Of Ion Transmembrane Transporter Activity Regulation Of Transmembrane Transporter Activity	Histone Modification Peptidyl-amino Acid Modification Chromatin Modification Peptidyl-arginine Methylation, To Asymmetrical-dimethyl Arginine Organelle Organization RNA Metabolic Process Chromatin Organization Peptidyl-arginine N-methylation Histone H4-R3 Methylation Histone Methylation Negative Regulation Of B Cell Proliferation Histone Arginine Methylation Peptidyl-arginine Methylation Regulation Of Megakaryocyte Differentiation Chromosome Organization Cell Development Protein Methylation Regulation Of RNA Metabolic Process Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator Nucleobase-containing Compound Metabolic Process Cellular Protein Modification Process Negative Regulation Of Cellular Metabolic Process Regulation Of Hematopoietic Progenitor Cell Differentiation Heterocycle Metabolic Process Cellular Aromatic Compound Metabolic Process Regulation Of Immune System Process Regulation Of Gene Expression Cell Differentiation Negative Regulation Of Gene Expression Regulation Of Nitrogen Compound Metabolic Process Negative Regulation Of B Cell Activation Negative Regulation Of Biosynthetic Process Cellular Nitrogen Compound Metabolic Process Regulation Of Signal Transduction By P53 Class Mediator Response To Hypoxia Regulation Of Cell Death Regulation Of Metabolic Process Developmental Process Nitrogen Compound Metabolic Process Protein Metabolic Process Regulation Of B Cell Proliferation Regulation Of Organelle Organization Negative Regulation Of Lymphocyte Proliferation Negative Regulation Of Mononuclear Cell Proliferation Negative Regulation Of Immune System Process Signal Transduction Involved In Mitotic G2 DNA Damage Checkpoint Regulation Of Primitive Erythrocyte Differentiation Negative Regulation Of Leukocyte Proliferation Response To Stimulus Cellular Protein Metabolic Process
Tagcloud ?		17q 2q35 5p 6p 9p bcg candidates demonstration dichotomy exacerbation examines helper histocompatibility il4 immunology inbred ity leishmania leishmanial leishmaniasis lsh mexicana mip1 nramp1 parasites pleiotropic positionally reflecting sigje	attributable contributes define downregulation emphasizes engineered genetically identifies implicating mammary mediator met neu overexpressing pharmacologic positively potentiation preexisting principal principally promoting protect recurrence relapse spontaneously sufficient turn upregulated
Tagcloud (Difference) ?		17q 2q35 5p 6p 9p bcg candidates demonstration dichotomy exacerbation examines helper histocompatibility il4 immunology inbred ity leishmania leishmanial leishmaniasis lsh mexicana mip1 nramp1 parasites pleiotropic positionally reflecting sigje	attributable contributes define downregulation emphasizes engineered genetically identifies implicating mammary mediator met neu overexpressing pharmacologic positively potentiation preexisting principal principally promoting protect recurrence relapse spontaneously sufficient turn upregulated
Tagcloud (Intersection) ?